Search results
Results from the Go Local Guru Content Network
The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. The primary goal of the Cancer Center is to ...
Sidney Farber (September 30, 1903 – March 30, 1973) was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia, which led to the development of other chemotherapeutic agents against other malignancies. Farber was also active in cancer research ...
Dana–Farber Cancer Institute. Laurie Hollis Glimcher (born 1951) is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. [1] She was elected a member of the American Philosophical Society in 2019. Glimcher has been at the center of controversies related to animal rights ...
Formerly called. Partners HealthCare (1994–2020) [1][2][3][4] Mass General Brigham (MGB) is a not-for-profit, [5] integrated health care system [6] that engages in medical research, [7] teaching, [8] and patient care. It is the largest hospital-based research enterprise in the United States, with annual funding of more than $2 billion. [9]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Dana–Farber Cancer Institute. David M. Livingston (29 March 1941 – 17 October 2021) [1] was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. [2] Dr.
Scientific career. Institutions. Dana–Farber Cancer Institute / Harvard Medical School. Judy Ellen Garber is the director of the Center for Cancer Genetics and Prevention at the Dana–Farber Cancer Institute and a professor of medicine at Harvard Medical School. Garber previously served as president of the American Association for Cancer ...
Matthew Langer Meyerson (born June 4, 1963) is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. [1] He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute, [2] and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.